🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 3 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/12/2002 27,30 30,00 27,00 30,00 +7,30% 10,99% 26.183
30/12/2002 28,62 29,46 27,30 27,96 -5,86% 7,55% 9.333
27/12/2002 30,00 30,42 28,50 29,70 -2,75% 6,40% 6.917
26/12/2002 31,20 31,20 30,00 30,54 -1,93% 3,85% 8.567
24/12/2002 30,66 31,14 29,88 31,14 +3,80% 4,11% 11.200
23/12/2002 30,00 31,20 28,80 30,00 -1,57% 8,00% 21.317
20/12/2002 29,40 30,60 29,40 30,48 +6,95% 4,08% 31.550
19/12/2002 30,00 30,00 28,50 28,50 -3,85% 5,00% 17.750
18/12/2002 30,42 30,48 29,10 29,64 -1,20% 4,54% 12.933
17/12/2002 31,44 31,44 28,56 30,00 +4,82% 9,16% 18.700
16/12/2002 28,86 29,40 28,26 28,62 +0,21% 3,95% 8.383
13/12/2002 30,00 30,12 28,50 28,56 -4,99% 5,40% 9.933
12/12/2002 29,16 30,90 28,80 30,06 +2,66% 7,20% 17.617
11/12/2002 28,56 30,00 28,32 29,28 +2,31% 5,88% 15.283
10/12/2002 28,50 28,62 26,40 28,62 +3,70% 7,79% 40.433
09/12/2002 32,94 32,94 27,30 27,60 -14,50% 17,12% 34.883
06/12/2002 33,54 33,54 31,62 32,28 +0,56% 5,72% 21.283
05/12/2002 32,70 36,00 31,74 32,10 -0,19% 13,03% 27.917
04/12/2002 33,18 33,24 31,62 32,16 -2,90% 4,88% 5.717
03/12/2002 33,24 34,50 31,62 33,12 -1,25% 8,66% 33.483
02/12/2002 34,80 37,14 32,22 33,54 -4,12% 14,14% 18.517
29/11/2002 36,90 36,90 34,92 34,98 -2,83% 5,37% 5.233
27/11/2002 35,82 37,50 35,70 36,00 +0,84% 5,03% 45.600
26/11/2002 36,30 37,56 34,62 35,70 -2,30% 8,10% 10.883
25/11/2002 38,34 38,34 36,00 36,54 -3,18% 6,10% 27.100
22/11/2002 37,50 38,28 36,00 37,74 -1,56% 6,08% 18.917
21/11/2002 35,94 40,38 35,40 38,34 +7,39% 13,86% 60.883
20/11/2002 33,00 35,94 32,16 35,70 +10,59% 11,45% 35.517
19/11/2002 30,60 32,46 30,18 32,28 +6,96% 7,45% 22.300
18/11/2002 27,66 30,96 26,70 30,18 +9,35% 15,40% 23.400